Compounds > nad
Page last updated: 2024-08-17

nad and Polycystic Ovary Syndrome

nad has been researched along with Polycystic Ovary Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE1
Cong, L; Li, H; Sun, Y; Wang, H; Wang, Y; Yang, Q; Zhu, J1
Assadi-Porter, FM; Bolandnazar, Z; Bütz, DE; Haviland, JA; Porter, WP; Selen, ES; Tonelli, M1
Balen, AH; Harris, SE; Maruthini, D; Picton, HM; Tang, T1
COHEN, RB; SCULLY, RE1
Andersen, RN; Coleman, SA; Givens, JR; Pittaway, DE; Wiser, WL1

Other Studies

6 other study(ies) available for nad and Polycystic Ovary Syndrome

ArticleYear
Declining muscle NAD
    Molecular metabolism, 2022, Volume: 65

    Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome

2022
NAD+ deficiency and mitochondrial dysfunction in granulosa cells of women with polycystic ovary syndrome‡.
    Biology of reproduction, 2021, 08-03, Volume: 105, Issue:2

    Topics: Adult; Cell Line, Tumor; Female; Granulosa Cells; Humans; Inflammation; Mitochondria; NAD; Polycystic Ovary Syndrome; Young Adult

2021
NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
    Journal of proteome research, 2015, Aug-07, Volume: 14, Issue:8

    Topics: Amino Acids; Animals; Biomarkers; Citric Acid Cycle; Disease Models, Animal; Female; Glucocorticoids; Humans; Hydroxybutyrates; Kidney; Magnetic Resonance Spectroscopy; Metabolic Diseases; Metabolome; Metabolomics; Mice; Mitochondria; NAD; Oxidative Stress; Pentose Phosphate Pathway; Polycystic Ovary Syndrome

2015
Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome.
    Human reproduction (Oxford, England), 2010, Volume: 25, Issue:9

    Topics: Adult; Carbohydrate Metabolism; Cell Differentiation; Cells, Cultured; Chromosome Aberrations; Chromosome Segregation; Chromosomes, Human, 21-22 and Y; Female; Humans; Hypoglycemic Agents; Meiosis; Metformin; Mitochondria; NAD; NADP; Oocytes; Ovarian Cysts; Ovulation Induction; Polycystic Ovary Syndrome; Spectral Karyotyping; Sperm Injections, Intracytoplasmic; Young Adult

2010
OXIDATIVE-ENZYME ACTIVITY IN NORMAL AND PATHOLOGIC HUMAN OVARIES.
    Obstetrics and gynecology, 1964, Volume: 24

    Topics: Adolescent; Female; Geriatrics; Glucosephosphate Dehydrogenase; Histocytochemistry; Humans; Isocitrate Dehydrogenase; L-Lactate Dehydrogenase; Luteinizing Hormone; NAD; Ovarian Neoplasms; Ovary; Polycystic Ovary Syndrome

1964
Human ovarian 17 beta-hydroxysteroid oxidoreductase activity: a comparison of normal and polycystic ovarian tissues.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 56, Issue:4

    Topics: 17-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Androstenedione; Corpus Luteum; Female; Humans; Menstruation; NAD; NADP; Ovary; Polycystic Ovary Syndrome; Testosterone; Veins

1983